PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals

• Glavni autori: Ji Young Kim (Autor), Ji Hye Shin (Autor), Mi-Jeong Kim (Autor), Bongkum Choi (Autor), Yeeun Kang (Autor), Jimin Choi (Autor), Seo Hyun Kim (Autor), Dohee Kwan (Autor), Duk-Hwan Kim (Autor), Eunyoung Chun (Autor), Ki-Young Lee (Autor)
• Format: Knjiga
• Izdano: BMC, 2024-05-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Abstract Protein tyrosine kinase 2 (PTK2), epidermal growth factor receptor (EGFR), and toll-like receptor (TLRs) are amplified in non-small cell lung cancer (NSCLC). However, the functional and clinical associations between them have not been elucidated yet in NSCLC. By using microarray data of non...